Perisylvian syndrome
Perisylvian syndrome is a rare neurological disorder characterized by impaired abilities to speak, express language (aphasia), and swallow (dysphagia). It is named for the region of the brain in which it is centered, the perisylvian region, which encompasses parts of the frontal lobe, parietal lobe, and temporal lobe.
Symptoms[edit | edit source]
The primary symptoms of Perisylvian syndrome include aphasia, dysphagia, and facial paralysis. These symptoms are due to damage or malformation in the perisylvian region of the brain, which is responsible for language and swallowing functions.
Causes[edit | edit source]
Perisylvian syndrome is typically caused by a malformation of the brain that occurs during fetal development. This malformation can be due to a variety of factors, including genetic mutations, maternal illness during pregnancy, or exposure to harmful substances in utero.
Diagnosis[edit | edit source]
Diagnosis of Perisylvian syndrome is typically made through a combination of clinical examination and imaging studies, such as MRI or CT scan. These tests can reveal the characteristic abnormalities in the perisylvian region of the brain.
Treatment[edit | edit source]
Treatment for Perisylvian syndrome is primarily supportive and focuses on managing the symptoms. This may include speech and language therapy for aphasia, physical therapy for facial paralysis, and nutritional support for dysphagia.
Prognosis[edit | edit source]
The prognosis for individuals with Perisylvian syndrome varies widely and depends on the severity of the symptoms and the extent of the brain malformation. Some individuals may have mild symptoms and lead relatively normal lives, while others may require lifelong care and support.
See also[edit | edit source]
Perisylvian syndrome Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD